Androgen synthesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Hormone and Metabolic Research

Volumn 45, Issue 2, 2013, Pages 86-91

  Kamrath, C ^a   Hartmann, M F ^a   Wudy, S A ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

17 hydroxyallopregnanolone; backdoor pathway; virilization

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTERONE; PREGNENOLONE; STEROID 17ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE; STEROID 5ALPHA REDUCTASE 1; TESTOSTERONE;

ADRENAL CORTEX; ADRENARCHE; ANDROGEN SYNTHESIS; BIOSYNTHESIS; BIOTRANSFORMATION; CATALYSIS; CHEMICAL REACTION; CONGENITAL ADRENAL HYPERPLASIA; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENOTYPE; HUMAN; MASS FRAGMENTOGRAPHY; METABOLOMICS; MICHAELIS CONSTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROID HYDROXYLATION; STEROID METABOLISM; TESTIS; URINALYSIS;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL CORTEX; ADRENAL HYPERPLASIA, CONGENITAL; ANDROGENS; ANIMALS; DIHYDROTESTOSTERONE; HUMANS; STEROID 17-ALPHA-HYDROXYLASE; STEROID 21-HYDROXYLASE;

EID: 84874107780     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1331751     Document Type: Review

References (32)

1. White P. C., Speiser P. W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev: 2000; 21 245 291
2. Wilson J. D. The role of 5α-reduction in steroid hormone physiology. Reprod Fertil Dev: 2001; 13 673 678
3. Auchus R. J., Lee T. C., Miller W. L. Cytochrome b5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J Biol Chem: 1998; 273 3158 3165
4. Pandey A. V., Miller W. L. Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem: 2005; 280 13265 13271
5. Flück C. E., Miller W. L., Auchus R. J. The 17, 20-lyase activity of cytochrome P450c17 from human fetal testis favors the Δ5 steroidogenic pathway. J Clin Endocrinol Metab: 2003; 88 3762 3766
6. Pang S., Levine L. S., Chow D. M., Faiman C., New M. I. Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol: 1979; 11 575 584
7. Kamrath C., Hochberg Z., Hartmann M. F., Remer T., Wudy S. A. Increased activation of the alternative backdoor' pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. J Clin Endocrinol Metab: 2012; 97 E367 E375
8. Remer T., Boye K. R., Hartmann M. F., Wudy S. A. Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. J Clin Endocrinol Metab: 2005; 90 2015 2021
9. Kamrath C., Hartmann M. F., Remer T., Wudy S. A. The Activities of 5a-Reductase and 17,20-Lyase Determine the Direction through Androgen Synthesis Pathways in Patients with 21-Hydroxylase Deficiency. Steroids: 2012; 77 1391 1397
10. Wilson J. D., Auchus R. J., Leihy M. W., Guryev O. L., Estabrook R. W., Osborn S. M., Shaw G., Renfree M. B. 5α-androstane-3α,17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α,17α-diol-20-one as a key intermediate. Endocrinology: 2003; 144 575 580
11. Shaw G., Fenelon J., Sichlau M., Auchus R. J., Wilson J. D., Renfree M. B. Role of the alternate pathway of dihydrotestosterone formation in virilization of the Wolffian ducts of the tammar wallaby, Macropus eugenii. Endocrinology: 2006; 147 2368 2373
12. Mahendroo M., Wilson J. D., Richardson J. A., Auchus R. J. Steroid 5alpha-reductase 1 promotes 5alpha-androstane-3alpha,17beta-diol synthesis in immature mouse testes by two pathways. Mol Cell Endocrinol: 2004; 222 113 120
13. Eckstein B., Borut A., Cohen S. Metabolic pathways for androstanediol formation in immature rat testis microsomes. Biochim Biophys Acta: 1987; 924 1 6
14. Auchus R. J. The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab: 2004; 15 432 438
15. Walsh P. C., Wilson J. D. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest: 1976; 57 1093 1097
16. Mohler J. L., Titus M. A., Bai S., Kennerley B. J., Lih F. B., Tomer K. B., Wilson E. M. Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer. Cancer Res: 2011; 71 1486 1496
17. Arlt W., Walker E. A., Draper N., Ivison H. E., Ride J. P., Hammer F., Chalder S. M., Borucka-Mankiewicz M., Hauffa B. P., Malunowicz E. M., Stewart P. M., Shackleton C. H. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet: 2004; 363 2128 2135
18. Homma K., Hasegawa T., Nagai T., Adachi M., Horikawa R., Fujiwara I., Tajima T., Takeda R., Fukami M., Ogata T. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. J Clin Endocrinol Metab: 2006; 91 2643 2649
19. Auchus R. J., Miller W. L. Congenital adrenal hyperplasia - more dogma bites the dust. J Clin Endocrinol Metab: 2012; 97 772 775
20. Frederiksen D. W., Wilson J. D. Partial characterization of the nuclear reduced nicotinamide adenine dinucleotide phosphate: Δ 4-3-ketosteroid 5α-oxidoreductase of rat prostate. J Biol Chem: 1971; 246 2584 2593
21. Flück C. E., Meyer-Böni M., Pandey A. V., Kempná P., Miller W. L., Schoenle E. J., Biason-Lauber A. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am J Hum Genet: 2011; 89 201 218
22. Penning T. M., Burczynski M. E., Jez J. M., Hung C. F., Lin H. K., Ma H., Moore M., Palackal N., Ratnam K. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J: 2000; 351 67 77
23. Gupta M. K., Guryev O. L., Auchus R. J. 5α-reduced C21 steroids are substrates for human cytochrome P450c17. Arch Biochem Biophys: 2003; 418 151 160
24. Dufort I., Labrie F., Luu-The V. Human types 1 and 3 3α- hydroxysteroid dehydrogenases: differential lability and tissue distribution. J Clin Endocrinol Metab: 2001; 86 841 846
25. Dufort I., Rheault P., Huang X. F., Soucy P., Luu-The V. Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology: 1999; 140 568 574
26. Luu-The V., Dufort I., Pelletier G., Labrie F. Type 5 17β-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Mol Cell Endocrinol: 2001; 171 77 82
27. Belyaeva O. V., Chetyrkin S. V., Clark A. L., Kostereva N. V., SantaCruz K. S., Chronwall B. M., Kedishvili N. Y. Role of microsomal retinol/sterol dehydrogenase-like short-chain dehydrogenases/reductases in the oxidation and epimerization of 3alpha-hydroxysteroids in human tissues. Endocrinology: 2007; 148 2148 2156
28. Claahsen-van der Grinten H. L., Noordam K., Borm G. F., Otten B. J. Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab: 2006; 91 1205 1209
29. Ong K., Hochberg Z. Editor's Choise. A new chapter in steroid metabolism: Infants take the backdoor. In: Ong K., Hochberg Z. eds. Yearbook of Pediatric Endocrinology 2012. Basel, Switzerland Karger: 2012; 219 220
30. Speiser P. W., Dupont J., Zhu D., Serrat J., Buegeleisen M., Tusie-Luna M. T., Lesser M., New M. I., White P. C. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest: 1992; 90 584 595
31. Krone N., Braun A., Roscher A. A., Knorr D., Schwarz H. P. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab: 2000; 85 1059 1065
32. Speiser P. W. Faculty of 1000. 2012; online http://f1000.com/13488998